| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2893240 | Atherosclerosis | 2010 | 5 Pages |
Abstract
Miglustat appears to have beneficial effects on plasma lipid, lipoprotein, and CRP concentrations in therapy-naïve GD1 patients, resulting in an improved atherogenic lipid profile. Further studies are required to determine the effect of miglustat on coronary heart disease risk.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
J. Puzo, P. Alfonso, P. Irun, J. Gervas, M. Pocovi, P. Giraldo,